These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9538942)
1. Cell-specific differences in the susceptibility of potential cellular targets of human origin derived from blood and lung following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Lang DS; Becker S; Devlin RB; Koren HS Cell Biol Toxicol; 1998 Feb; 14(1):23-38. PubMed ID: 9538942 [TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. van Duursen MB; Sanderson JT; van den Berg M Toxicol Sci; 2005 May; 85(1):703-12. PubMed ID: 15659568 [TBL] [Abstract][Full Text] [Related]
3. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities. Vogel C; Donat S; Döhr O; Kremer J; Esser C; Roller M; Abel J Arch Toxicol; 1997; 71(6):372-82. PubMed ID: 9195019 [TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 1A1 induction in rat lymphoid tissues following in vivo and in vitro exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin requires protein kinase C. Stephen FD; Drahushuk AT; Olson JR Toxicology; 1997 Dec; 124(1):39-51. PubMed ID: 9392454 [TBL] [Abstract][Full Text] [Related]
5. 2,3,7,8-TCDD induces cytochrome P450 enzyme activity but not proliferation or phenotypical changes in human peripheral blood lymphocytes. Lang DS; Becker S; Devlin RB; Koren HS Toxicol Lett; 1996 Nov; 88(1-3):317-25. PubMed ID: 8920755 [TBL] [Abstract][Full Text] [Related]
6. Estradiol enhances and estriol inhibits the expression of CYP1A1 induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a mouse ovarian cancer cell line. Son DS; Roby KF; Rozman KK; Terranova PF Toxicology; 2002 Jul; 176(3):229-43. PubMed ID: 12093619 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced CYP1A1 gene expression profile in lymphocytes from mice, rats, and humans: most potent induction in humans. Nohara K; Ao K; Miyamoto Y; Ito T; Suzuki T; Toyoshiba H; Tohyama C Toxicology; 2006 Aug; 225(2-3):204-13. PubMed ID: 16839655 [TBL] [Abstract][Full Text] [Related]
8. Lack of direct immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitro. Lang DS; Becker S; Clark GC; Devlin RB; Koren HS Arch Toxicol; 1994; 68(5):296-302. PubMed ID: 8085940 [TBL] [Abstract][Full Text] [Related]
9. CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Vanden Heuvel JP; Clark GC; Thompson CL; McCoy Z; Miller CR; Lucier GW; Bell DA Carcinogenesis; 1993 Oct; 14(10):2003-6. PubMed ID: 8222045 [TBL] [Abstract][Full Text] [Related]
10. Comparative assessment of metabolic enzyme levels in macrophage populations of the F344 rat. Germolec DR; Adams NH; Luster MI Biochem Pharmacol; 1995 Oct; 50(9):1495-504. PubMed ID: 7503801 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate. Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892 [TBL] [Abstract][Full Text] [Related]
12. Effects of o,p'-DDT on the 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible CYP1A1 expression in murine Hepa-1c1c7 cells. Jeong HG; Kim JY Food Chem Toxicol; 2002 Nov; 40(11):1685-92. PubMed ID: 12176094 [TBL] [Abstract][Full Text] [Related]
13. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Vanden Heuvel JP; Clark GC; Kohn MC; Tritscher AM; Greenlee WF; Lucier GW; Bell DA Cancer Res; 1994 Jan; 54(1):62-8. PubMed ID: 8261464 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of aryl hydrocarbon receptor antagonists: inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression. Merchant M; Morrison V; Santostefano M; Safe S Arch Biochem Biophys; 1992 Nov; 298(2):389-94. PubMed ID: 1329656 [TBL] [Abstract][Full Text] [Related]
15. Induction of CYP1A1 and ALDH-3 in lymphoid tissues from Fisher 344 rats exposed to 2,3,7,8-tetrachlorodibenzodioxin (TCDD). Germolec DR; Henry EC; Maronpot R; Foley JF; Adams NH; Gasiewicz TA; Luster MI Toxicol Appl Pharmacol; 1996 Mar; 137(1):57-66. PubMed ID: 8607142 [TBL] [Abstract][Full Text] [Related]
16. 2,3,7,8 Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes. Xu L; Li AP; Kaminski DL; Ruh MF Chem Biol Interact; 2000 Feb; 124(3):173-89. PubMed ID: 10728777 [TBL] [Abstract][Full Text] [Related]
17. TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident. Landi MT; Bertazzi PA; Baccarelli A; Consonni D; Masten S; Lucier G; Mocarelli P; Needham L; Caporaso N; Grassman J Carcinogenesis; 2003 Apr; 24(4):673-80. PubMed ID: 12727795 [TBL] [Abstract][Full Text] [Related]
18. Expression of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P4501A1 in human splenic lymphocyte cultures. Jeong HG; Yang KH Cancer Lett; 1996 Jan; 98(2):193-8. PubMed ID: 8556708 [TBL] [Abstract][Full Text] [Related]
19. Effects of zearalenone on mRNA expression and activity of cytochrome P450 1A1 and 1B1 in MCF-7 cells. Yu Z; Hu D; Li Y Ecotoxicol Environ Saf; 2004 Jun; 58(2):187-93. PubMed ID: 15157572 [TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]